| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162274 Inhibition of steroid synthesis by use of progesterone or a progesterone receptor agonist |
| 08/19/2004 | US20040161476 Aqueous solution; bladder and urogenital disorders |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2515516A1 Carboxylic acid compounds |
| 08/19/2004 | CA2515235A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists |
| 08/19/2004 | CA2514028A1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/18/2004 | EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1447096A1 Remedies for urinary frequency |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP1446104A1 Spray drying methods and compositions thereof |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1175397B1 3,3-substituted indoline derivatives |
| 08/18/2004 | EP1144361B1 Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester |
| 08/18/2004 | EP1060240B1 Lactobacillus strain |
| 08/18/2004 | EP0944599B1 Triarylethanes useful as pde iv inhibitors |
| 08/18/2004 | EP0744950B1 Agent for prophylaxis and treatment of thromboxane a2 mediated diseases |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522257A Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 08/18/2004 | CN1522151A Modified fvii in treatment of ards |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1522142A Potassium channel opener |
| 08/18/2004 | CN1520842A Liposoluble suppository for treating prostatitis |
| 08/18/2004 | CN1162432C 2,3-benzodiazepine derivatives |
| 08/18/2004 | CN1162429C Tricyclic vasopressin agonists |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/17/2004 | USRE38566 Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |
| 08/17/2004 | US6777416 Isoxazolo pyrimidinones and the use thereof |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777386 Peptide agonist or analogue other than deslorelin; lecithin and stearin; preferably comprises a gnrh agonist and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial |
| 08/17/2004 | CA2292921C Aryl carboxylic acid and tetrazole derivatives |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/12/2004 | WO2004067535A1 Thienopyrimidine compounds and use thereof |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004067003A1 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 08/12/2004 | WO2004067002A2 SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT |
| 08/12/2004 | WO2004066991A1 Enteric sustained-release fine particles for tamsulosin or its salt and process for producing the same |
| 08/12/2004 | WO2004066990A2 Methods of treating lower urinary tract disorders using sodium channel modulators |
| 08/12/2004 | WO2003106444A8 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/12/2004 | WO2003037863A3 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | US20040157930 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157913 Irritable bowel syndrome ; gastrointestinal disorders |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157889 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 08/12/2004 | US20040157888 Method of treating of demyelinating diseases or conditions |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157858 Piperazine derivatives as tachykinin antagonists |
| 08/12/2004 | US20040157857 Substituted chroman derivatives |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/12/2004 | US20040157799 Pharmaceutical uses of bisphosphonates |
| 08/12/2004 | US20040157785 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/12/2004 | US20040157778 computer program, which can be used for obtaining optimized dosage regimens for a desired pharmacodynamic response |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157227 uses detection of relatively increased levels of ghrelin, an exon 3-deleted form of preproghrelin and/or growth hormone secretagogue type 1b receptor expression |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156925 Plant proanthocyanidin extract effective at inhibiting utility |
| 08/12/2004 | US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156827 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 08/12/2004 | US20040156787 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic theraphy and in vivo diagnostic |
| 08/12/2004 | CA2515585A1 Enteric sustained-release fine particles for tamsulosin or its salt and manufacturing method thereof |
| 08/12/2004 | CA2514581A1 Methods of treating lower urinary tract disorders using sodium channel modulators |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/12/2004 | CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/11/2004 | EP1445253A1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/11/2004 | EP1444981A1 Intracellular calcium concentration increase inhibitors |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1444235A1 Reverse-turn mimetics and method relating thereto |
| 08/11/2004 | EP1444232A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase |
| 08/11/2004 | EP1444227A1 Thiazolyl substituted triazoles as alk5 inhibitors |
| 08/11/2004 | EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 08/11/2004 | EP1444220A1 Compounds and method for the treatment of overactive bladder |
| 08/11/2004 | EP1444219A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
| 08/11/2004 | EP1444212A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 08/11/2004 | EP1444210A1 Qunazoline derivatives as antitumor agents |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444199A1 Racemic tamsulosin free base and methods of making the same |
| 08/11/2004 | EP1444198A1 Process for resolution of tamsulosin |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443939A1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |